GEN | News Highlights:NIAID Funds Malaria Vaccine Project

Antigen Discovery won a $2.5 million three-year Phase II Small Business Innovation and Research Grant from the National Institute of Allergy and Infectious Diseases to continue a program focused on identifying Plasmodium falciparum antigens associated with protection against malaria. The funds will support a collaboration between the firm and Sanaria, which is using Antigen Discovery’s proteome microarrays to identify biomarkers associated with response to the administration of Sanaria’s malaria products in human trials, including Sanaria PfSPZ Vaccine (radiation attenuated sporozoites), Sanaria PfSPZ Challenge (fully infectious sporozoites), and Sanaria PfSPZ-CVac (PfSPZ Challenge administered with malaria chemoprophylaxis).

via GEN | News Highlights:NIAID Funds Malaria Vaccine Project.

Advertisements


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s